Cargando…

Reprogramming Sacral Neuromodulation for Sub‐Optimal Outcomes: Evidence and Recommendations for Clinical Practice

OBJECTIVES: In some patients treated for urinary or fecal incontinence with sacral neuromodulation (SNM) persistence of symptoms, a reduction in efficacy or adverse effects of stimulation can occur. In such situations, further programming of the SNM device can help resolve problems. Infrequently har...

Descripción completa

Detalles Bibliográficos
Autores principales: Dudding, Thomas C., Lehur, Paul A., Sørensen, Michael, Engelberg, Stefan, Bertapelle, Maria Paola, Chartier‐Kastler, Emmanuel, Everaert, Karel, Van Kerrebroeck, Philip, Knowles, Charles H., Lundby, Lilli, Matzel, Klaus E., Muñoz‐Duyos, Arantxa, Rydningen, Mona B., de Wachter, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291141/
https://www.ncbi.nlm.nih.gov/pubmed/34264542
http://dx.doi.org/10.1111/ner.13494
_version_ 1784749075017498624
author Dudding, Thomas C.
Lehur, Paul A.
Sørensen, Michael
Engelberg, Stefan
Bertapelle, Maria Paola
Chartier‐Kastler, Emmanuel
Everaert, Karel
Van Kerrebroeck, Philip
Knowles, Charles H.
Lundby, Lilli
Matzel, Klaus E.
Muñoz‐Duyos, Arantxa
Rydningen, Mona B.
de Wachter, Stefan
author_facet Dudding, Thomas C.
Lehur, Paul A.
Sørensen, Michael
Engelberg, Stefan
Bertapelle, Maria Paola
Chartier‐Kastler, Emmanuel
Everaert, Karel
Van Kerrebroeck, Philip
Knowles, Charles H.
Lundby, Lilli
Matzel, Klaus E.
Muñoz‐Duyos, Arantxa
Rydningen, Mona B.
de Wachter, Stefan
author_sort Dudding, Thomas C.
collection PubMed
description OBJECTIVES: In some patients treated for urinary or fecal incontinence with sacral neuromodulation (SNM) persistence of symptoms, a reduction in efficacy or adverse effects of stimulation can occur. In such situations, further programming of the SNM device can help resolve problems. Infrequently hardware failure is detected. This article aims to provide practical guidance to solve sub‐optimal outcomes (troubleshooting) occurring in the course of SNM therapy. MATERIALS AND METHODS: A systematic literature review was performed. Collective clinical experience from an expert multidisciplinary group was used to form opinion where evidence was lacking. RESULTS: Circumstances in which reprogramming is required are described. Actions to undertake include changes of electrode configuration, stimulation amplitude, pulse frequency, and pulse width. Guidance in case of loss of efficacy and adverse effects of stimulation, developed by a group of European experts, is presented. In addition, various hardware failure scenarios and their management are described. CONCLUSIONS: Reprogramming aims to further improve patient symptoms or ensure a comfortable delivery of the therapy. Initial changes of electrode configuration and adjustment of stimulation parameters can be performed at home to avoid unnecessary hospital visits. A logical and stepwise approach to reprogramming can improve the outcome of therapy and restore patient satisfaction.
format Online
Article
Text
id pubmed-9291141
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-92911412022-07-20 Reprogramming Sacral Neuromodulation for Sub‐Optimal Outcomes: Evidence and Recommendations for Clinical Practice Dudding, Thomas C. Lehur, Paul A. Sørensen, Michael Engelberg, Stefan Bertapelle, Maria Paola Chartier‐Kastler, Emmanuel Everaert, Karel Van Kerrebroeck, Philip Knowles, Charles H. Lundby, Lilli Matzel, Klaus E. Muñoz‐Duyos, Arantxa Rydningen, Mona B. de Wachter, Stefan Neuromodulation GASTROINTESTINAL DISORDERS AND GENITOURINARY DISORDERS OBJECTIVES: In some patients treated for urinary or fecal incontinence with sacral neuromodulation (SNM) persistence of symptoms, a reduction in efficacy or adverse effects of stimulation can occur. In such situations, further programming of the SNM device can help resolve problems. Infrequently hardware failure is detected. This article aims to provide practical guidance to solve sub‐optimal outcomes (troubleshooting) occurring in the course of SNM therapy. MATERIALS AND METHODS: A systematic literature review was performed. Collective clinical experience from an expert multidisciplinary group was used to form opinion where evidence was lacking. RESULTS: Circumstances in which reprogramming is required are described. Actions to undertake include changes of electrode configuration, stimulation amplitude, pulse frequency, and pulse width. Guidance in case of loss of efficacy and adverse effects of stimulation, developed by a group of European experts, is presented. In addition, various hardware failure scenarios and their management are described. CONCLUSIONS: Reprogramming aims to further improve patient symptoms or ensure a comfortable delivery of the therapy. Initial changes of electrode configuration and adjustment of stimulation parameters can be performed at home to avoid unnecessary hospital visits. A logical and stepwise approach to reprogramming can improve the outcome of therapy and restore patient satisfaction. John Wiley & Sons, Inc. 2021-07-15 2021-10 /pmc/articles/PMC9291141/ /pubmed/34264542 http://dx.doi.org/10.1111/ner.13494 Text en © 2021 The Authors. Neuromodulation: Technology at the Neural Interface published by Wiley Periodicals LLC on behalf of International Neuromodulation Society. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle GASTROINTESTINAL DISORDERS AND GENITOURINARY DISORDERS
Dudding, Thomas C.
Lehur, Paul A.
Sørensen, Michael
Engelberg, Stefan
Bertapelle, Maria Paola
Chartier‐Kastler, Emmanuel
Everaert, Karel
Van Kerrebroeck, Philip
Knowles, Charles H.
Lundby, Lilli
Matzel, Klaus E.
Muñoz‐Duyos, Arantxa
Rydningen, Mona B.
de Wachter, Stefan
Reprogramming Sacral Neuromodulation for Sub‐Optimal Outcomes: Evidence and Recommendations for Clinical Practice
title Reprogramming Sacral Neuromodulation for Sub‐Optimal Outcomes: Evidence and Recommendations for Clinical Practice
title_full Reprogramming Sacral Neuromodulation for Sub‐Optimal Outcomes: Evidence and Recommendations for Clinical Practice
title_fullStr Reprogramming Sacral Neuromodulation for Sub‐Optimal Outcomes: Evidence and Recommendations for Clinical Practice
title_full_unstemmed Reprogramming Sacral Neuromodulation for Sub‐Optimal Outcomes: Evidence and Recommendations for Clinical Practice
title_short Reprogramming Sacral Neuromodulation for Sub‐Optimal Outcomes: Evidence and Recommendations for Clinical Practice
title_sort reprogramming sacral neuromodulation for sub‐optimal outcomes: evidence and recommendations for clinical practice
topic GASTROINTESTINAL DISORDERS AND GENITOURINARY DISORDERS
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291141/
https://www.ncbi.nlm.nih.gov/pubmed/34264542
http://dx.doi.org/10.1111/ner.13494
work_keys_str_mv AT duddingthomasc reprogrammingsacralneuromodulationforsuboptimaloutcomesevidenceandrecommendationsforclinicalpractice
AT lehurpaula reprogrammingsacralneuromodulationforsuboptimaloutcomesevidenceandrecommendationsforclinicalpractice
AT sørensenmichael reprogrammingsacralneuromodulationforsuboptimaloutcomesevidenceandrecommendationsforclinicalpractice
AT engelbergstefan reprogrammingsacralneuromodulationforsuboptimaloutcomesevidenceandrecommendationsforclinicalpractice
AT bertapellemariapaola reprogrammingsacralneuromodulationforsuboptimaloutcomesevidenceandrecommendationsforclinicalpractice
AT chartierkastleremmanuel reprogrammingsacralneuromodulationforsuboptimaloutcomesevidenceandrecommendationsforclinicalpractice
AT everaertkarel reprogrammingsacralneuromodulationforsuboptimaloutcomesevidenceandrecommendationsforclinicalpractice
AT vankerrebroeckphilip reprogrammingsacralneuromodulationforsuboptimaloutcomesevidenceandrecommendationsforclinicalpractice
AT knowlescharlesh reprogrammingsacralneuromodulationforsuboptimaloutcomesevidenceandrecommendationsforclinicalpractice
AT lundbylilli reprogrammingsacralneuromodulationforsuboptimaloutcomesevidenceandrecommendationsforclinicalpractice
AT matzelklause reprogrammingsacralneuromodulationforsuboptimaloutcomesevidenceandrecommendationsforclinicalpractice
AT munozduyosarantxa reprogrammingsacralneuromodulationforsuboptimaloutcomesevidenceandrecommendationsforclinicalpractice
AT rydningenmonab reprogrammingsacralneuromodulationforsuboptimaloutcomesevidenceandrecommendationsforclinicalpractice
AT dewachterstefan reprogrammingsacralneuromodulationforsuboptimaloutcomesevidenceandrecommendationsforclinicalpractice